Quarterly report pursuant to Section 13 or 15(d)

Collaboration and Research Arrangements - Schedule of Change in Accounts Receivable, Contract Assets and Liabilities (Details)

Collaboration and Research Arrangements - Schedule of Change in Accounts Receivable, Contract Assets and Liabilities (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2023 USD ($)
Disaggregation Of Revenue [Line Items]
Contract liabilities, Balance at Beginning of Period	$ 4,330
Contract liabilities, Additions	173
Contract liabilities, Deductions	4,364
Contract liabilities, Balance at End of Period	139
Global Blood Therapeutics
Disaggregation Of Revenue [Line Items]
Contract liabilities, Balance at Beginning of Period	4,330
Contract liabilities, Additions	173
Contract liabilities, Deductions	4,364
Contract liabilities, Balance at End of Period	$ 139

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details